On March 7, 2022, Zogenix, Inc. was acquired by UCB. For more information, please visit www.linkedin.com/company/ucb-pharma.
View Top Employees from Zogenix, Inc.Website | http://www.ucb.com |
Ticker | ZGNX |
Revenue | $17 million |
Funding | $1.3 billion |
Employees | 145 (145 on RocketReach) |
Founded | 2006 |
Address | 5959 Horton St, Emeryville, California 94608, US |
Phone | (510) 550-8300 |
Technologies |
JavaScript,
HTML,
Twitter
+79 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Biotechnology, CNS Disorders, Pharmaceuticals, Science and Engineering, Epilepsy, Healthcare, Health Care, Pharmaceutical |
Web Rank | 3 Million |
Keywords | Pharmaceutical Companies, Rare Disease, Central Nervous System, Pain Management, Neurological Care, Epilepsy Care, Orphan Drug Development, Neuroscience, Drug Development And Manufacturing |
Competitors | Alexza / Ferrer, MediQuest Therapeutics, Inc., Sage Therapeutics, Supernus Pharmaceuticals, Inc., Vanda Pharmaceuticals |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Zogenix, Inc. employee's phone or email?
The Zogenix, Inc. annual revenue was $17 million in 2024.
Carey Aron is the Executive Director, Medical Affairs of Zogenix, Inc..
145 people are employed at Zogenix, Inc..
Zogenix, Inc. is based in Emeryville, California.
The NAICS codes for Zogenix, Inc. are [3254, 32, 32541, 325].
The SIC codes for Zogenix, Inc. are [28, 283].